Home/Filings/4/0001942459-24-000011
4//SEC Filing

Bornstein Jonathan 4

Accession 0001942459-24-000011

CIK 0001899287other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 5:53 PM ET

Size

7.0 KB

Accession

0001942459-24-000011

Insider Transaction Report

Form 4
Period: 2024-04-12
Bornstein Jonathan
President of Amprius Lab
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-04-121,007,8671 total
    Exercise: $0.05From: 2022-09-14Exp: 2027-03-15Common stock (1,007,867 underlying)
  • Exercise/Conversion

    Common stock

    2024-04-12$0.05/sh+1,007,867$50,3931,566,797 total
Footnotes (1)
  • [F1]Includes 558,930 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Issuer

Amprius Technologies, Inc.

CIK 0001899287

Entity typeother

Related Parties

1
  • filerCIK 0001942459

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 5:53 PM ET
Size
7.0 KB